Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs
13/11/2025 12:07
Nov 13 (Reuters) - Telehealth company Mangoceuticals MGRX.O said on Thursday it has partnered with Eli Lilly LLY.N and Novo Nordisk NOVOb.CO to sell the drugmakers' blockbuster weight-loss drugs through its platform. (Reporting by Christy Santhosh in Bengaluru) ((Christy.Santhosh@thomsonreuters.com;))
Recent news on Mangoceuticals
See all newsBrief: Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM